UniProt ID | TGM2_HUMAN | |
---|---|---|
UniProt AC | P21980 | |
Protein Name | Protein-glutamine gamma-glutamyltransferase 2 | |
Gene Name | TGM2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 687 | |
Subcellular Localization | ||
Protein Description | Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins.. | |
Protein Sequence | MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTPANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYLDSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFEDGILDICLILLDVNPKFLKNAGRDCSRRSSPVYVGRVVSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPGYEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHKSINRSLIVGLKISTKSVGRDEREDITHTYKYPEGSSEEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTAEEYVCRLLLCARTVSYNGILGPECGTKYLLNLNLEPFSEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQKRKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPVEAGEEVKVRMDLLPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEELVLER ------CCHHHHHHH | 20.97 | 22814378 | |
10 | S-nitrosocysteine | EELVLERCDLELETN HHHHHHHCCEEEECC | 5.24 | - | |
10 | S-nitrosylation | EELVLERCDLELETN HHHHHHHCCEEEECC | 5.24 | 22178444 | |
27 | S-nitrosocysteine | DHHTADLCREKLVVR CCCHHHHHHCEEEEE | 5.63 | - | |
27 | S-nitrosylation | DHHTADLCREKLVVR CCCHHHHHHCEEEEE | 5.63 | 22178444 | |
53 | Phosphorylation | EGRNYEASVDSLTFS CCCCEEEEEEEEEEE | 17.95 | 24275569 | |
56 | Phosphorylation | NYEASVDSLTFSVVT CEEEEEEEEEEEEEE | 27.44 | 24275569 | |
60 | Phosphorylation | SVDSLTFSVVTGPAP EEEEEEEEEEECCCC | 15.50 | 24275569 | |
98 | S-nitrosocysteine | TVVDQQDCTLSLQLT EEECCCCCEEEEEEE | 3.42 | - | |
98 | S-nitrosylation | TVVDQQDCTLSLQLT EEECCCCCEEEEEEE | 3.42 | 22178444 | |
143 | S-nitrosylation | ILLFNAWCPADAVYL HHHHEECCCCCEEEE | 1.53 | 22178444 | |
143 | S-nitrosocysteine | ILLFNAWCPADAVYL HHHHEECCCCCEEEE | 1.53 | - | |
159 | Phosphorylation | SEEERQEYVLTQQGF CHHHHHHHEEEECCE | 7.75 | - | |
202 | Acetylation | ILLDVNPKFLKNAGR HHHCCCHHHHHHCCC | 59.11 | 30592923 | |
205 | Acetylation | DVNPKFLKNAGRDCS CCCHHHHHHCCCCCC | 48.13 | 22424773 | |
205 | Malonylation | DVNPKFLKNAGRDCS CCCHHHHHHCCCCCC | 48.13 | 26320211 | |
212 | Phosphorylation | KNAGRDCSRRSSPVY HHCCCCCCCCCCCEE | 34.71 | 22142843 | |
215 | Phosphorylation | GRDCSRRSSPVYVGR CCCCCCCCCCEEECE | 37.57 | 23403867 | |
216 | Phosphorylation | RDCSRRSSPVYVGRV CCCCCCCCCEEECEE | 19.30 | 28355574 | |
219 | Phosphorylation | SRRSSPVYVGRVVSG CCCCCCEEECEEEEC | 10.69 | 23403867 | |
230 | S-nitrosylation | VVSGMVNCNDDQGVL EEECCEECCCCCCEE | 3.93 | 22178444 | |
230 | S-nitrosocysteine | VVSGMVNCNDDQGVL EEECCEECCCCCCEE | 3.93 | - | |
245 | Phosphorylation | LGRWDNNYGDGVSPM EEEECCCCCCCCCCC | 23.89 | - | |
250 | Phosphorylation | NNYGDGVSPMSWIGS CCCCCCCCCCHHHCH | 22.03 | - | |
265 | 2-Hydroxyisobutyrylation | VDILRRWKNHGCQRV HHHHHHHHHCCCCEE | 36.94 | - | |
269 | S-nitrosylation | RRWKNHGCQRVKYGQ HHHHHCCCCEEEECH | 1.49 | 22178444 | |
269 | S-nitrosocysteine | RRWKNHGCQRVKYGQ HHHHHCCCCEEEECH | 1.49 | - | |
277 | S-nitrosocysteine | QRVKYGQCWVFAAVA CEEEECHHHHHHHHH | 2.65 | - | |
277 | S-nitrosylation | QRVKYGQCWVFAAVA CEEEECHHHHHHHHH | 2.65 | 22178444 | |
285 | S-nitrosylation | WVFAAVACTVLRCLG HHHHHHHHHHHHHHC | 1.86 | 22178444 | |
285 | S-nitrosocysteine | WVFAAVACTVLRCLG HHHHHHHHHHHHHHC | 1.86 | - | |
315 | Phosphorylation | NSNLLIEYFRNEFGE CCCHHHHHHHHHCCC | 10.80 | - | |
336 | S-nitrosylation | EMIWNFHCWVESWMT HEEEEEEEEEEHHCC | 3.68 | 22178444 | |
336 | S-nitrosocysteine | EMIWNFHCWVESWMT HEEEEEEEEEEHHCC | 3.68 | - | |
365 | Phosphorylation | DPTPQEKSEGTYCCG CCCCCCCCCCEEECC | 40.27 | 26356563 | |
368 | Phosphorylation | PQEKSEGTYCCGPVP CCCCCCCEEECCCEE | 14.88 | 28152594 | |
369 | Phosphorylation | QEKSEGTYCCGPVPV CCCCCCEEECCCEEE | 9.15 | 21082442 | |
370 | S-nitrosocysteine | EKSEGTYCCGPVPVR CCCCCEEECCCEEEC | 1.86 | - | |
370 | S-nitrosylation | EKSEGTYCCGPVPVR CCCCCEEECCCEEEC | 1.86 | 22178444 | |
371 | S-nitrosocysteine | KSEGTYCCGPVPVRA CCCCEEECCCEEECE | 4.93 | - | |
371 | S-nitrosylation | KSEGTYCCGPVPVRA CCCCEEECCCEEECE | 4.93 | 22178444 | |
385 | Phosphorylation | AIKEGDLSTKYDAPF EEEECCCCCCCCCCE | 27.82 | 24275569 | |
415 | Phosphorylation | DDGSVHKSINRSLIV CCCCEECEECHHHEE | 15.37 | 23403867 | |
419 | Phosphorylation | VHKSINRSLIVGLKI EECEECHHHEEEEEE | 20.26 | 23403867 | |
427 | Phosphorylation | LIVGLKISTKSVGRD HEEEEEEEECCCCCC | 28.35 | 18187866 | |
429 | 2-Hydroxyisobutyrylation | VGLKISTKSVGRDER EEEEEEECCCCCCCC | 36.03 | - | |
449 | Phosphorylation | TYKYPEGSSEEREAF EEECCCCCHHHHHHH | 32.68 | 28857561 | |
450 | Phosphorylation | YKYPEGSSEEREAFT EECCCCCHHHHHHHH | 55.09 | 28857561 | |
464 | Ubiquitination | TRANHLNKLAEKEET HHHHHHHHHHHHHHH | 56.27 | - | |
468 | Acetylation | HLNKLAEKEETGMAM HHHHHHHHHHHCCEE | 56.07 | - | |
468 | 2-Hydroxyisobutyrylation | HLNKLAEKEETGMAM HHHHHHHHHHHCCEE | 56.07 | - | |
483 | Sulfoxidation | RIRVGQSMNMGSDFD EEECCCCCCCCCCCE | 2.84 | 30846556 | |
485 | Sulfoxidation | RVGQSMNMGSDFDVF ECCCCCCCCCCCEEE | 3.99 | 30846556 | |
524 | S-nitrosylation | NGILGPECGTKYLLN CCEECCCCCCEEEEE | 10.64 | 22178444 | |
524 | S-nitrosocysteine | NGILGPECGTKYLLN CCEECCCCCCEEEEE | 10.64 | - | |
538 | Phosphorylation | NLNLEPFSEKSVPLC ECCCCCCCCCCCCEE | 55.63 | 21712546 | |
541 | Phosphorylation | LEPFSEKSVPLCILY CCCCCCCCCCEEEHH | 25.56 | 21712546 | |
545 | S-nitrosylation | SEKSVPLCILYEKYR CCCCCCEEEHHHHHH | 1.32 | 22178444 | |
545 | S-nitrosocysteine | SEKSVPLCILYEKYR CCCCCCEEEHHHHHH | 1.32 | - | |
554 | S-palmitoylation | LYEKYRDCLTESNLI HHHHHHHHCCCCCCC | 3.61 | 26865113 | |
554 | S-nitrosylation | LYEKYRDCLTESNLI HHHHHHHHCCCCCCC | 3.61 | 2212679 | |
562 | 2-Hydroxyisobutyrylation | LTESNLIKVRALLVE CCCCCCCCHHHHHHH | 28.91 | - | |
575 | Phosphorylation | VEPVINSYLLAERDL HHHHHHHHHHHHCCC | 10.97 | - | |
583 | Phosphorylation | LLAERDLYLENPEIK HHHHCCCCCCCCCCE | 19.09 | - | |
590 | 2-Hydroxyisobutyrylation | YLENPEIKIRILGEP CCCCCCCEEEECCCH | 25.03 | - | |
590 | Acetylation | YLENPEIKIRILGEP CCCCCCCEEEECCCH | 25.03 | 23236377 | |
590 | Ubiquitination | YLENPEIKIRILGEP CCCCCCCEEEECCCH | 25.03 | - | |
598 | 2-Hydroxyisobutyrylation | IRILGEPKQKRKLVA EEECCCHHHHCEEEE | 65.24 | - | |
608 | Phosphorylation | RKLVAEVSLQNPLPV CEEEEEEECCCCCCC | 18.75 | 24275569 | |
620 | S-nitrosocysteine | LPVALEGCTFTVEGA CCCEEECCEEEEECC | 1.75 | - | |
620 | S-nitrosylation | LPVALEGCTFTVEGA CCCEEECCEEEEECC | 1.75 | 22178444 | |
649 | 2-Hydroxyisobutyrylation | VEAGEEVKVRMDLLP CCCCCCEEEEEEEEE | 27.66 | - | |
649 | Acetylation | VEAGEEVKVRMDLLP CCCCCCEEEEEEEEE | 27.66 | 23236377 | |
649 | Ubiquitination | VEAGEEVKVRMDLLP CCCCCCEEEEEEEEE | 27.66 | - | |
672 | 2-Hydroxyisobutyrylation | VVNFESDKLKAVKGF EEECCCHHHHHCCCC | 62.25 | - | |
672 | Acetylation | VVNFESDKLKAVKGF EEECCCHHHHHCCCC | 62.25 | 25825284 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TGM2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TGM2_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00130 | L-Glutamine |
loading...
Phosphorylation | |
Reference | PubMed |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-219 AND TYR-369, ANDMASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-369, AND MASSSPECTROMETRY. |